{
  "schemaVersion" : 2,
  "registerId" : "F2019L00637",
  "instrumentNumber" : "59/2019",
  "citation" : "Statement of Principles concerning gout (Reasonable Hypothesis) (No. 59 of 2019)",
  "conditionName" : "gout",
  "effectiveFrom" : "2019-05-27",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "M10"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "9(1)",
    "text" : "having a haematological disorder from the specified list of\r\nhaematological disorders at the time of the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(2)",
    "text" : "being treated with a drug from a class of drugs from the specified list of\r\nantihypertensive drugs for a continuous period of at least seven days,\r\nbefore the clinical onset of gout, where the last dose of the drug was\r\ntaken within the three months before the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(3)",
    "text" : "being treated with daily doses of low-dose aspirin (≤ 325 milligrams)\r\nfor two consecutive days, before the clinical onset of gout, where the\r\nlast dose of the drug was taken within the 48 hours before the clinical\r\nonset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(4)",
    "text" : "being treated with a drug or a drug from a class of drugs from the\r\nSpecified List 1 of drugs within the 48 hours before the clinical onset\r\nof gout",
    "definedTerms" : [ {
      "term" : "Specified List 1 of drugs",
      "definition" : "means:\r\n(a) allopurinol;\r\n(b) azathioprine;\r\n(c) cyclosporine;\r\n(d) ethambutol;\r\n(e) gemcitabine;\r\n(f) levodopa;\r\n(g) mycophenolate;\r\n(h) non-losartan angiotensin II receptor blockers (ARBs);\r\n(i) probenecid;\r\n(j) pyrazinamide;\r\n(k) sildenafil; or\r\n(l) tacrolimus (excluding topical application)."
    } ]
  }, {
    "paragraph" : "9(5)",
    "text" : "undergoing chemotherapy for a malignant neoplasm within the seven\r\ndays before the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(6)",
    "text" : "being overweight at the time of the clinical onset of gout",
    "definedTerms" : [ {
      "term" : "being overweight",
      "definition" : "means having a Body Mass Index (BMI) of 25 or greater.\r\nNote: BMI is also defined in the Schedule 1 - Dictionary."
    } ]
  }, {
    "paragraph" : "9(7)",
    "text" : "consuming an average of at least 120 grams per week of alcohol, for at\r\nleast the three months before the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(8)",
    "text" : "consuming at least 70 grams of alcohol within the 48 hours before the\r\nclinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(9)",
    "text" : "consuming an average of at least 750 grams per week of meat or offal,\r\nfor at least the three months before the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(10)",
    "text" : "consuming at least 300 grams of meat or offal within the 48 hours\r\nbefore the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(11)",
    "text" : "consuming an average of at least 120 grams per week of seafood, for at\r\nleast the three months before the clinical onset of gout",
    "definedTerms" : [ {
      "term" : "seafood",
      "definition" : "means shellfish or fish."
    } ]
  }, {
    "paragraph" : "9(12)",
    "text" : "consuming at least 120 grams of seafood within the 48 hours before the\r\nclinical onset of gout",
    "definedTerms" : [ {
      "term" : "seafood",
      "definition" : "means shellfish or fish."
    } ]
  }, {
    "paragraph" : "9(13)",
    "text" : "consuming an average of at least 400 millilitres per day of:\r\n(a) fruit juice; or\r\n(b) non-diet soft drink or other manufactured drink sweetened with\r\nfructose or sucrose;\r\nalone or in any combination, for at least the three months before the\r\nclinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(14)",
    "text" : "fasting for a continuous period of at least 24 hours within the 48 hours\r\nbefore the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(15)",
    "text" : "being dehydrated for a continuous period of at least 24 hours within the\r\n48 hours before the clinical onset of gout",
    "definedTerms" : [ {
      "term" : "being dehydrated",
      "definition" : "means being deficient in body water, such as could occur\r\nafter strenuous physical activity, vomiting, diarrhoea or febrile illness,\r\nwithout adequate rehydration."
    } ]
  }, {
    "paragraph" : "9(16)",
    "text" : "being postmenopausal at the time of the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(17)",
    "text" : "having a solid organ transplant, stem cell transplant or bone marrow\r\ntransplant before the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(18)",
    "text" : "having surgery within the 48 hours before the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(19)",
    "text" : "having lead nephropathy before the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(20)",
    "text" : "having psoriasis or psoriatic arthritis at the time of the clinical onset of\r\ngout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(21)",
    "text" : "having chronic kidney disease at the time of the clinical onset of gout",
    "definedTerms" : [ {
      "term" : "chronic kidney disease",
      "definition" : "means an abnormality of kidney structure or function\r\nthat has been present for at least three months.\r\nNote: abnormality of kidney structure or function is also defined in the Schedule 1 - Dictionary."
    } ]
  }, {
    "paragraph" : "9(22)",
    "text" : "having hypertension before the clinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(23)",
    "text" : "having dyslipidaemia before the clinical onset of gout",
    "definedTerms" : [ {
      "term" : "dyslipidaemia",
      "definition" : "means persistently abnormal blood lipid levels, diagnosed by a\r\nmedical practitioner and evidenced by:\r\n(a) a total serum cholesterol level greater than 5.5 mmol/L; or\r\n(b) a serum low density lipoprotein level greater than 4.0 mmol/L; or\r\n(c) a serum high density lipoprotein cholesterol level less than 1.0\r\nmmol/L; or\r\n(d) the regular administration of drug therapy to normalise blood lipid\r\nlevels.\r\ngout—see subsection 7(2)."
    } ]
  }, {
    "paragraph" : "9(24)",
    "text" : "undergoing total parenteral nutrition within the 48 hours before the\r\nclinical onset of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(25)",
    "text" : "having trauma to the affected joint or tissue within the 48 hours before\r\nthe clinical onset of gout",
    "definedTerms" : [ ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "9(26)",
    "text" : "having a haematological disorder from the specified list of\r\nhaematological disorders at the time of the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(27)",
    "text" : "being treated with a drug from a class of drugs from the specified list of\r\nantihypertensive drugs for a continuous period of at least seven days,\r\nbefore the clinical worsening of gout, where the last dose of the drug\r\nwas taken within the three months before the clinical worsening of\r\ngout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(28)",
    "text" : "being treated with daily doses of low-dose aspirin (≤ 325 milligrams)\r\nfor two consecutive days, before the clinical worsening of gout, where\r\nthe last dose of the drug was taken within the 48 hours before the\r\nclinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(29)",
    "text" : "being treated with a drug or a drug from a class of drugs from the\r\nSpecified List 2 of drugs at the time of the clinical worsening of gout",
    "definedTerms" : [ {
      "term" : "Specified List 2 of drugs",
      "definition" : "means:\r\n(a) allopurinol;\r\n(b) azathioprine;\r\n(c) cyclosporine;\r\n(d) ethambutol;\r\n(e) febuxostat;\r\n(f) gemcitabine;\r\n(g) levodopa;\r\n(h) mycophenolate;\r\n(i) non-losartan angiotensin II receptor blockers (ARBs);\r\n(j) probenecid;\r\n(k) pyrazinamide;\r\n(l) sildenafil; or\r\n(m) tacrolimus (excluding topical application)."
    } ]
  }, {
    "paragraph" : "9(30)",
    "text" : "undergoing chemotherapy for a malignant neoplasm within the seven\r\ndays before the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(31)",
    "text" : "being overweight at the time of the clinical worsening of gout",
    "definedTerms" : [ {
      "term" : "being overweight",
      "definition" : "means having a Body Mass Index (BMI) of 25 or greater.\r\nNote: BMI is also defined in the Schedule 1 - Dictionary."
    } ]
  }, {
    "paragraph" : "9(32)",
    "text" : "consuming an average of at least 120 grams per week of alcohol, for at\r\nleast the three months before the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(33)",
    "text" : "consuming at least 70 grams of alcohol within the 48 hours before the\r\nclinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(34)",
    "text" : "consuming an average of at least 750 grams per week of meat or offal,\r\nfor at least the three months before the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(35)",
    "text" : "consuming at least 300 grams of meat or offal within the 48 hours\r\nbefore the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(36)",
    "text" : "consuming an average of at least 120 grams per week of seafood, for at\r\nleast the three months before the clinical worsening of gout",
    "definedTerms" : [ {
      "term" : "seafood",
      "definition" : "means shellfish or fish."
    } ]
  }, {
    "paragraph" : "9(37)",
    "text" : "consuming at least 120 grams of seafood within the 48 hours before the\r\nclinical worsening of gout",
    "definedTerms" : [ {
      "term" : "seafood",
      "definition" : "means shellfish or fish."
    } ]
  }, {
    "paragraph" : "9(38)",
    "text" : "consuming an average of at least 400 millilitres per day of:\r\n(a) fruit juice; or\r\n(b) non-diet soft drink or other manufactured drink sweetened with\r\nfructose or sucrose;\r\nalone or in any combination, for at least the three months before the\r\nclinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(39)",
    "text" : "fasting for a continuous period of at least 24 hours within the 48 hours\r\nbefore the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(40)",
    "text" : "being dehydrated for a continuous period of at least 24 hours within the\r\n48 hours before the clinical worsening of gout",
    "definedTerms" : [ {
      "term" : "being dehydrated",
      "definition" : "means being deficient in body water, such as could occur\r\nafter strenuous physical activity, vomiting, diarrhoea or febrile illness,\r\nwithout adequate rehydration."
    } ]
  }, {
    "paragraph" : "9(41)",
    "text" : "being postmenopausal at the time of the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(42)",
    "text" : "having a solid organ transplant, stem cell transplant or bone marrow\r\ntransplant before the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(43)",
    "text" : "having surgery within the 48 hours before the clinical worsening of\r\ngout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(44)",
    "text" : "having lead nephropathy before the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(45)",
    "text" : "having psoriasis or psoriatic arthritis at the time of the clinical\r\nworsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(46)",
    "text" : "having chronic kidney disease at the time of the clinical worsening of\r\ngout",
    "definedTerms" : [ {
      "term" : "chronic kidney disease",
      "definition" : "means an abnormality of kidney structure or function\r\nthat has been present for at least three months.\r\nNote: abnormality of kidney structure or function is also defined in the Schedule 1 - Dictionary."
    } ]
  }, {
    "paragraph" : "9(47)",
    "text" : "having hypertension before the clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(48)",
    "text" : "having dyslipidaemia before the clinical worsening of gout",
    "definedTerms" : [ {
      "term" : "dyslipidaemia",
      "definition" : "means persistently abnormal blood lipid levels, diagnosed by a\r\nmedical practitioner and evidenced by:\r\n(a) a total serum cholesterol level greater than 5.5 mmol/L; or\r\n(b) a serum low density lipoprotein level greater than 4.0 mmol/L; or\r\n(c) a serum high density lipoprotein cholesterol level less than 1.0\r\nmmol/L; or\r\n(d) the regular administration of drug therapy to normalise blood lipid\r\nlevels.\r\ngout—see subsection 7(2)."
    } ]
  }, {
    "paragraph" : "9(49)",
    "text" : "undergoing total parenteral nutrition within the 48 hours before the\r\nclinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(50)",
    "text" : "having trauma to the affected joint or tissue within the 48 hours before\r\nthe clinical worsening of gout",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(51)",
    "text" : "inability to obtain appropriate clinical management for gout",
    "definedTerms" : [ ]
  } ]
}